During the past decade, Westdeutsches Tumorzentrum conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Westdeutsches Tumorzentrum" #1 sponsor was "EMD Serono Research & Development Institute, Inc." with 2 trials, followed by "Technische Universität Dresden" with 2 trials sponsored, "AIO-Studien-gGmbH" with 1 trials sponsored, "Daiichi Sankyo, Inc." with 1 trials sponsored and "Thoraxklinik-Heidelberg gGmbH" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Westdeutsches Tumorzentrum" #1 collaborator was "Merck KGaA, Darmstadt, Germany" with 2 trials as a collaborator, "German Research Foundation" with 1 trials as a collaborator, "Immodulon Therapeutics Ltd" with 1 trials as a collaborator, "Optimapharm" with 1 trials as a collaborator and "Roche Pharma AG" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Westdeutsches Tumorzentrum" are "Colorectal Cancer" (2 trials), "Acute Lymphoblastic Leukaemia" (1 trials), "Advanced Solid Tumors" (1 trials), "Giant Cell Tumors" (1 trials) and "Leukemia, Myeloid, Acute" (1 trials). Many other conditions were trialed in "Westdeutsches Tumorzentrum" in a lesser frequency.

Most popular intervention types in "Westdeutsches Tumorzentrum" are "Drug" (8 trials), "Biological" (1 trials), "Procedure" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Cetuximab" (2 trials), "Cisplatin" (2 trials), "Atezolizumab" (1 trials), "Avelumab" (1 trials) and "Cetuximab and FOLFIRI" (1 trials). Other intervention names were less common.

The vast majority of trials in "Westdeutsches Tumorzentrum" are 9 trials for "All" genders.

Currently, there are NaN active trials in "Westdeutsches Tumorzentrum". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Westdeutsches Tumorzentrum, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Westdeutsches Tumorzentrum, 3 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".